Web Stats Provided By Google Analytics

Saturday, November 17, 2018

Zacks Investment Research Downgrades Eiger Biopharmaceuticals (EIGR) to Hold

... Global LLC purchased a new stake in Eiger Biopharmaceuticals during the second quarter worth $277,000. Finally, Ardsley Advisory Partners purchased a new stake in Eiger Biopharmaceuticals during the second quarter worth $305,000. Institutional ...
https://www.dailypolitical.com/2018/11/17/zacks-investment-research-downgrades-eiger-biopharmaceuticals-eigr-to-hold.html

No comments:

Post a Comment

Popular Ardsley Roundup Posts